Sourced from:Manufacturer Authorized Distributor
Quick Summary
Ipca MMF S 360 Tablet
Last updated on 02 Jul 2026 | 09:41 AM (IST)
₹482
MRP: ₹659.8
(You Save ₹177.8)
10 TABLET(s) IN A STRIP
Sourced from:Manufacturer Authorized Distributor
27% OFF
₹482
MRP: ₹659.80
Inclusive of all taxes
27% Off
Substitutes
Graftide S 360mg Tablet
MYLAN PHARMACEU...
₹ 35.90/tablet
25% cheaper
Mycomune S 360mg Tablet
ZYDUS CADILA
₹ 35.90/tablet
25% cheaper
Myfocept S 360mg Tablet
APRAZER HEALTHC...
₹ 36.80/tablet
23% cheaper
Mofecon S 360mg Tablet
CONCORD BIOTECH...
₹ 40.00/tablet
17% cheaper
Introduction
Ipca MMF S 360 Tablet is an immunosuppressant with an active ingredient called Mycophenolate sodium. It belongs to the inosine monophosphate dehydrogenase (IMPDH) inhibitor category. This medicine is used to prevent organ rejection in individuals who have previously received an organ transplant (such as kidney, heart, or liver transplantation). It is prescribed as part of a combination therapy that includes other immunosuppressive drugs.
This drug is contraindicated during pregnancy due to the risk of birth defects and miscarriage. It should not be advised in pregnant women unless there are no relevant alternatives and the potential benefits outweigh the risks. Female patients with reproductive potential are highly advised to use effective contraception while taking this tablet to prevent pregnancy. Live vaccines should not be administered while a person is taking Ipca MMF S 360 tablet due to reduced vaccine effectiveness and the risk of infection. Individuals taking this drug should not donate blood during treatment and at least six weeks after stopping treatment. It ensures that the medication has been adequately cleared from the body before donating blood.
It is generally advised not to take this medicine if you are allergic to the drug or any other ingredients. Inform your doctor if you have liver or heart disease before initiating the treatment. As this drug reduces the body's immune defenses, it can increase the chance of skin cancer. Individuals must take precautions to limit their exposure to sunlight and ultraviolet (UV) light. Seek your doctor immediately if you develop any bruising under the skin, fever, unexplained tiredness, dizziness, yellowing of the skin or eyes, vision impairment, reduced urine output, and seizures after taking this medicine. Ipca MMF S 360 tablet is an immunosuppressive medication. It may affect the infant's developing immune system and should be avoided in breastfeeding. Ipca Mmf S 360 Tablet price varies by retailer and location. You Can buy Ipca Mmf S 360 Tablet online at MrMed for Affordable Prices.
Uses
Ipca Mmf S Tablet uses are:
Prevent organ transplant rejections.
How Ipca MMF S 360 Tablet Works
Ipca MMF S 360 tablet works by inhibiting the enzyme inosine monophosphate dehydrogenase (IMPDH) and reducing the production of guanosine nucleotides. MMF specifically affects the proliferation of activated T and B lymphocytes. These lymphocytes are key players in the immune response that can lead to the rejection of a transplanted organ.
Interaction of Ipca MMF S 360 Tablet with other drugs
Inform your doctor about all your medicines, such as over-the-counter medications, prescription medications, vaccinations, nutritional and vitamin supplements, and herbal products. Certain groups of medications may interact with the effects of Ipca MMF S 360 tablet and reduce its effectiveness by causing undesirable side effects.
Storage Conditions
Store Ipca MMF S 360 tablet at room temperature between (15°C to 30°C)
Keep the medicine away from the reach of children and pets.
How to take Ipca MMF S 360 Tablet
It is an orally available prescription drug. Your physician will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Always take Ipca MMF S 360 tablet as prescribed by your doctor. Do not open, crush, break, or chew the medicine. Take the medicine at the same time every day as advised by your doctor.
Safety Advice for Ipca MMF S 360 Tablet
Breast Feeding
Ipca MMF S 360 tablet is not recommended for breastfeeding mothers because small amounts of the drug can pass into the mother's milk and affect the nursing baby.
Alcohol
It is unsafe to consume alcohol when taking Ipca MMF S 360 tablet because it may cause excessive drowsiness or liver problems.
Liver
Ipca MMF S 360 tablet should be cautiously administered in patients with lung diseases. Dose adjustments are necessary. Inform your physician if you have lung problems before initiating the therapy.
Lungs
It is generally considered safe for individuals with liver disease; however, inform your physician if you have any liver diseases.
Driving
Driving vehicles or operating machinery while taking Ipca MMF S 360 tablet is unsafe because it may cause drowsiness and vision problems.
Pregnancy
Ipca MMF S 360 tablet is known to have harmful effects on the developing fetus and is generally not taken during pregnancy unless your doctor prescribes the medicine.
Side Effects
Ipca Mmf S Tablet Side Effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
Infections, fever, or sore throat
Unusual bleeding or bruising
Low blood cell count
Severe allergic reactions
Common
Higher risk of developing lymphoma and other cancers
Nausea, abdominal pain
Diarrhea
Constipation
Loss of appetite
Shortness of breath
Weight loss
Increased heartbeat
Headache
Blood pressure problem
Anaemia
Expert tips
Follow Prescribed Dosage: Take the Ipca MMF S 360 tablet exactly as directed by your doctor without skipping or adjusting doses on your own.
Disclose All Medications: Inform your doctor about all prescription, over-the-counter, and herbal medicines you are using to avoid possible drug interactions.
Consult During Pregnancy: If you are planning to conceive or suspect pregnancy, consult your doctor immediately for safer alternatives or treatment adjustments.
Follow Medical Guidance: Always use this medication under strict medical supervision to ensure safety and effectiveness.
FAQs about Ipca MMF S 360 Tablet
Q1.
Can I breastfeed while taking Ipca MMF S 360 tablet?
Breastfeeding is generally not recommended while taking Ipca MMF S 360 tablet. This drug can pass into the mother's breast milk and may hurt the nursing infant. Consult your doctor about breastfeeding if you are taking this tablet.
Q2.
How does Ipca MMF S 360 tablet work?
Ipca MMF S 360 tablet suppresses the immune system, preventing it from attacking the transplanted organ. It inhibits the activity of certain immune cells involved in the rejection process.
Q3.
What will happen if I stop taking Ipca MMF S 360 tablet suddenly?
Stopping your treatment all of a sudden may cause your condition to become worse. Do not stop taking Ipca MMF S 360 tablet without consulting your doctor.
Q4.
How should I take Ipca MMF S 360 tablet?
Follow the instructions advised by your doctor or the medication label. Ipca MMF S 360 tablet is taken orally with food to improve absorption. It should be swallowed, not chewed or broken.
Q5.
Can I drink alcohol while taking Ipca MMF S 360 tablet?
It is highly recommended to limit or avoid alcohol consumption while taking Ipca MMF S 360 tablet. Alcohol can interact with the medication, increasing the risk of side effects or interfering with its effectiveness.
Q6.
Whether Ipca MMF S 360 tablet can cause miscarriage?
Yes, Ipca MMF S 360 tablet can cause miscarriage. If you have childbearing potential, use effective contraception before or during treatment and at least six weeks after discontinuing the medication. Discuss contraceptive options with your doctor properly.
Q7.
Can I get vaccinated during the treatment with Ipca MMF S 360 tablet?
Live vaccines should be avoided while taking Ipca MMF S 360 tablet due to the risk of infection. Inform your healthcare provider about your immunization history and consult them regarding the appropriate timing of vaccinations.
Fact Box
Molecule name: Mycophenolate sodium | Therapeutic class: Immunosuppressants |
Pharmacological class: Inosine monophosphate dehydrogenase (IMPDH) inhibitor | Indications: Prevent organ transplant rejections |
References
- Novartis Ireland Limited, European Medicine Consortium (EMC), [Revised on Nov 2022], [Accessed on 25/05/2023], https://www.medicines.org.uk/emc/files/pil.5560.pdf
- S.E. Marshall, Immunological Factors in Disease, Davidson's Principles and Practice of Medicine, 22nd Edition, 2014, 71-96.
- KD Tripathi, Immunosuppressant Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019,.937-945.
- Goodman & Gilman's, The Pharmacological Basis of Therapeutics, Inflammation, Immunomodulation, and Hematopoiesis, 12th Edition, 2011, 1014.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. B. Deiva
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 02 Jul 2026 | 09:41 AM (IST)
Want to know more?
Read Our Editorial Policy
